| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Royalty revenues | $593K-13.2% | $683K+40.0% | $488K+26.4% | $386K |
| Research and development | $35.3M-4.1% | $36.9M+12.2% | $32.9M+21.2% | $27.1M |
| Selling, general and administrative | $14.2M+14.0% | $12.5M-4.3% | $13.0M-1.0% | $13.2M |
| Total operating expenses | $49.6M+0.4% | $49.3M+7.5% | $45.9M+13.9% | $40.3M |
| Loss from operations | -$49.0M-0.6% | -$48.7M-7.1% | -$45.4M-13.8% | -$39.9M |
| Interest income | $3.1M-4.8% | $3.3M-19.9% | $4.1M+157.4% | $1.6M |
| Other income (expense), net | $5K+112.8% | -$39K+60.2% | -$98K | — |
| Total other income (expense), net | $3.1M-3.4% | $3.2M-18.9% | $4.0M+231.5% | $1.2M |
| Net loss | -$45.9M-0.9% | -$45.4M-9.6% | -$41.4M-7.1% | -$38.7M |
| Preferred stock dividend payable on Series A Convertible Preferred Stock | -$25K-4.2% | -$24K+0.0% | -$24K+0.0% | -$24K |
| Net loss attributable to common stockholders | -$45.9M-0.9% | -$45.5M-9.6% | -$41.5M-7.1% | -$38.7M |
| Net loss per common share - basic | -$690.00+27.4% | -$950.00-2.2% | -$930.00-4.5% | -$890.00 |
| Net loss per common share - diluted | -$690.00+27.4% | -$950.00-2.2% | -$930.00-4.5% | -$890.00 |
| Weighted-average shares outstanding - basic | 66.8M+40.3% | 47.6M+6.7% | 44.7M+2.5% | 43.6M |
| Weighted-average shares outstanding - diluted | 66.8M+40.3% | 47.6M+6.7% | 44.7M+2.5% | 43.6M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.